[1]
Shojaeefar, E., Ghaffari, M., Mohammadi, M., Hosseini, J. and Omrani, M.D. 2020. What we Know so far about Myxovirus Resistance Protein A (MxA) as a Biomarker of Interferon-Beta Therapy in Patients with Multiple Sclerosis: a Systematic Review. Archives of Men’s Health. 3, 1 (Dec. 2020), e19. DOI:https://doi.org/10.22037/mhj.v3i1.33124.